1st Quarter - Termination
ERVIN GRAVES STRATEGY GROUP, LLC for LYNDRA THERAPEUTICS
Client
Income
$40,000
Expenses
—
Terminated
Feb 28, 2022
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
NO CONTACTS: Only Monitor and advise client on Defense Appropriations Act for Fiscal Year 2022 - ultra-long medicine delivery platform National Defense Authorization Act for Fiscal Year 2022 - ultra-long medicine delivery platform Labor Health & Human Services and Education Fiscal Year 2022 Appropriations Bill - ultra-long medicine delivery platform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | — |
| COLBY MILLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.